We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Nuclear Receptor ROR-Gamma industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
Market Segment by Product Application
Hospital
Clinic
Others
Finally, the report provides detailed profile and data information analysis of leading company.
4SC AG
Celgene Corporation
Aurigene Discovery Technologies Limited
Advinus Therapeutics Ltd.
Bristol-Myers Squibb Company
Arrien Pharmaceuticals, LLC
Genfit SA
Brickell Biotech, Inc.
Biogen, Inc.
Genentech, Inc.
Nuevolution AB
Teijin Pharma Limited
GlaxoSmithKline Plc
Vitae Pharmaceuticals, Inc.
Phenex Pharmaceuticals AG
Lead Pharma Holding B.V.
Hanmi Pharmaceuticals, Co. Ltd.
Visionary Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc.
Karo Bio AB
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Nuclear Receptor ROR-Gamma consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Nuclear Receptor ROR-Gamma market by identifying its various subsegments.
3.Focuses on the key global Nuclear Receptor ROR-Gamma manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Nuclear Receptor ROR-Gamma with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Nuclear Receptor ROR-Gamma submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Nuclear Receptor ROR-Gamma Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Nuclear Receptor ROR-Gamma Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Nuclear Receptor ROR-Gamma Segment by Type
2.1.1 VPR-66
2.1.2 INV-17
2.1.3 GSK-2981278
2.1.4 BBI-6000
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Others
2.3 Global Nuclear Receptor ROR-Gamma Market Comparison by Regions (2017-2027)
2.3.1 Global Nuclear Receptor ROR-Gamma Market Size (2017-2027)
2.3.2 North America Nuclear Receptor ROR-Gamma Status and Prospect (2017-2027)
2.3.3 Europe Nuclear Receptor ROR-Gamma Status and Prospect (2017-2027)
2.3.4 Asia-pacific Nuclear Receptor ROR-Gamma Status and Prospect (2017-2027)
2.3.5 South America Nuclear Receptor ROR-Gamma Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Nuclear Receptor ROR-Gamma Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Nuclear Receptor ROR-Gamma Industry Impact
2.5.1 Nuclear Receptor ROR-Gamma Business Impact Assessment - Covid-19
2.5.2 Market Trends and Nuclear Receptor ROR-Gamma Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Nuclear Receptor ROR-Gamma Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Nuclear Receptor ROR-Gamma Manufacturer Market Share
3.5 Top 10 Nuclear Receptor ROR-Gamma Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Nuclear Receptor ROR-Gamma Market
3.7 Key Manufacturers Nuclear Receptor ROR-Gamma Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Nuclear Receptor ROR-Gamma Industry Key Manufacturers
4.1 4SC AG
4.1.1 Company Details
4.1.2 4SC AG Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.1.3 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 4SC AG News
4.2 Celgene Corporation
4.2.1 Company Details
4.2.2 Celgene Corporation Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.2.3 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Celgene Corporation News
4.3 Aurigene Discovery Technologies Limited
4.3.1 Company Details
4.3.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.3.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Aurigene Discovery Technologies Limited News
4.4 Advinus Therapeutics Ltd.
4.4.1 Company Details
4.4.2 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.4.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Advinus Therapeutics Ltd. News
4.5 Bristol-Myers Squibb Company
4.5.1 Company Details
4.5.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.5.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Bristol-Myers Squibb Company News
4.6 Arrien Pharmaceuticals, LLC
4.6.1 Company Details
4.6.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.6.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Arrien Pharmaceuticals, LLC News
4.7 Genfit SA
4.7.1 Company Details
4.7.2 Genfit SA Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.7.3 Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Genfit SA News
4.8 Brickell Biotech, Inc.
4.8.1 Company Details
4.8.2 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.8.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Brickell Biotech, Inc. News
4.9 Biogen, Inc.
4.9.1 Company Details
4.9.2 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.9.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Biogen, Inc. News
4.10 Genentech, Inc.
4.10.1 Company Details
4.10.2 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.10.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Genentech, Inc. News
4.11 Nuevolution AB
4.11.1 Company Details
4.11.2 Nuevolution AB Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.11.3 Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Nuevolution AB News
4.12 Teijin Pharma Limited
4.12.1 Company Details
4.12.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.12.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Teijin Pharma Limited News
4.13 GlaxoSmithKline Plc
4.13.1 Company Details
4.13.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.13.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 GlaxoSmithKline Plc News
4.14 Vitae Pharmaceuticals, Inc.
4.14.1 Company Details
4.14.2 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.14.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Vitae Pharmaceuticals, Inc. News
4.15 Phenex Pharmaceuticals AG
4.15.1 Company Details
4.15.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.15.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Phenex Pharmaceuticals AG News
4.16 Lead Pharma Holding B.V.
4.16.1 Company Details
4.16.2 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.16.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Lead Pharma Holding B.V. News
4.17 Hanmi Pharmaceuticals, Co. Ltd.
4.17.1 Company Details
4.17.2 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.17.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Hanmi Pharmaceuticals, Co. Ltd. News
4.18 Visionary Pharmaceuticals, Inc.
4.18.1 Company Details
4.18.2 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.18.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Visionary Pharmaceuticals, Inc. News
4.19 Reata Pharmaceuticals, Inc.
4.19.1 Company Details
4.19.2 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.19.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Reata Pharmaceuticals, Inc. News
4.20 Karo Bio AB
4.20.1 Company Details
4.20.2 Karo Bio AB Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
4.20.3 Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 Karo Bio AB News
5 Global Nuclear Receptor ROR-Gamma Sales Categorized by Regions
5.1 Global Nuclear Receptor ROR-Gamma Revenue, Sales and Market Share by Regions
5.1.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Regions (2017-2022)
5.1.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Regions (2017-2022)
5.2 North America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
5.3 Europe Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
5.5 South America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
6 North America Nuclear Receptor ROR-Gamma Market Size Categorized by Countries
6.1 North America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Countries
6.1.1 North America Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
6.1.2 North America Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
6.1.3 United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
6.1.4 Canada Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
6.1.5 Mexico Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
6.2 North America Nuclear Receptor ROR-Gamma Revenue (Value) by Manufacturers
6.3 North America Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2017-2022)
6.4 North America Nuclear Receptor ROR-Gamma Sales Market Share by Application (2017-2022)
7 Europe Nuclear Receptor ROR-Gamma Market Size Categorized by Countries
7.1 Europe Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Countries
7.1.1 Europe Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
7.1.3 Germany Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
7.1.4 UK Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
7.1.5 France Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
7.1.6 Russia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
7.1.7 Italy Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
7.1.8 Spain Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
7.2 Europe Nuclear Receptor ROR-Gamma Revenue (Value) by Manufacturers
7.3 Europe Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2017-2022)
7.4 Europe Nuclear Receptor ROR-Gamma Sales Market Share by Application (2017-2022)
8 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Categorized by Countries
8.1 Asia-pacific Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
8.1.3 China Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
8.1.4 South Korea Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
8.1.5 Japan Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
8.1.6 Australia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
8.1.7 India Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Nuclear Receptor ROR-Gamma Revenue (Value) by Manufacturers
8.3 Asia-pacific Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Nuclear Receptor ROR-Gamma Sales Market Share by Application (2017-2022)
9 South America Nuclear Receptor ROR-Gamma Market Size Categorized by Countries
9.1 South America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Countries
9.1.1 South America Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
9.1.2 South America Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
9.1.3 Brazil Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
9.2 South America Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2017-2022)
9.3 South America Nuclear Receptor ROR-Gamma Sales Market Share by Application (2017-2022)
10 Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Categorized by Countries
10.1 Middle East and Africa Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
10.1.3 GCC Countries Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
10.1.4 Turkey Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
10.1.5 Egypt Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
10.1.6 South America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Nuclear Receptor ROR-Gamma Sales and Market Share by Type
10.3 Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Application (2017-2022)
11 Global Nuclear Receptor ROR-Gamma Market Segment by Type
11.1 Global Nuclear Receptor ROR-Gamma Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2017-2022)
11.1.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2017-2022)
11.2 VPR-66 Sales Growth Rate and Price
11.2.1 Global VPR-66 Sales Growth Rate (2017-2022)
11.2.2 Global VPR-66 Price (2017-2022)
11.3 INV-17 Sales Growth Rate and Price
11.3.1 Global INV-17 Sales Growth Rate (2017-2022)
11.3.2 Global INV-17 Price (2017-2022)
11.4 GSK-2981278 Sales Growth Rate and Price
11.4.1 Global GSK-2981278 Sales Growth Rate (2017-2022)
11.4.2 Global GSK-2981278 Price (2017-2022)
11.5.1 Global BBI-6000 Sales Growth Rate (2017-2022)
11.5.2 Global BBI-6000 Price (2017-2022)
11.6 Others Sales Growth Rate and Price
11.6.1 Global Others Sales Growth Rate (2017-2022)
11.6.2 Global Others Price (2017-2022)
12 Global Nuclear Receptor ROR-Gamma Market Segment by Application
12.1 Global Nuclear Receptor ROR-Gamma Sales Market Share by Application (2017-2022)
12.2 Hospital Sales Growth Rate (2017-2022)
12.3 Clinic Sales Growth Rate (2017-2022)
12.4 Others Sales Growth Rate (2017-2022)
13 Global Nuclear Receptor ROR-Gamma Market Forecast
13.1 Global Nuclear Receptor ROR-Gamma Revenue, Sales and Growth Rate (2022-2027)
13.2 Nuclear Receptor ROR-Gamma Market Forecast by Regions (2022-2027)
13.2.1 North America Nuclear Receptor ROR-Gamma Market Forecast (2022-2027)
13.2.2 Europe Nuclear Receptor ROR-Gamma Market Forecast (2022-2027)
13.2.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Forecast (2022-2027)
13.2.4 South America Nuclear Receptor ROR-Gamma Market Forecast (2022-2027)
13.2.5 Middle East & Africa Nuclear Receptor ROR-Gamma Market Forecast (2022-2027)
13.3 Nuclear Receptor ROR-Gamma Market Forecast by Type (2022-2027)
13.3.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2022-2027)
13.3.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Type (2022-2027)
13.4 Nuclear Receptor ROR-Gamma Market Forecast by Application (2022-2027)
13.4.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2022-2027)
13.4.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Nuclear Receptor ROR-Gamma Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Nuclear Receptor ROR-Gamma Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Nuclear Receptor ROR-Gamma
Figure Market Concentration Ratio and Market Maturity Analysis of Nuclear Receptor ROR-Gamma
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Nuclear Receptor ROR-Gamma Market Size by Type
Figure Global Market Share of Nuclear Receptor ROR-Gamma by Type in 2021
Figure VPR-66 Picture
Figure INV-17 Picture
Figure GSK-2981278 Picture
Figure BBI-6000 Picture
Figure Others Picture
Table Global Nuclear Receptor ROR-Gamma Market Size (Volume) by Application
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Nuclear Receptor ROR-Gamma Comparison by Regions (M USD) 2017-2027
Figure Global Nuclear Receptor ROR-Gamma Market Size (Million US$) (2017-2027)
Figure North America Nuclear Receptor ROR-Gamma Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Nuclear Receptor ROR-Gamma Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Nuclear Receptor ROR-Gamma Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Nuclear Receptor ROR-Gamma Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Nuclear Receptor ROR-Gamma Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Nuclear Receptor ROR-Gamma Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Nuclear Receptor ROR-Gamma Sales by Manufacturer (2017-2022)
Figure Global Nuclear Receptor ROR-Gamma Sales Market Share by Manufacturer in 2021
Table Global Nuclear Receptor ROR-Gamma Revenue by Manufacturer (2017-2022)
Figure Global Nuclear Receptor ROR-Gamma Revenue Market Share by Manufacturer in 2021
Table Global Nuclear Receptor ROR-Gamma Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Nuclear Receptor ROR-Gamma Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Nuclear Receptor ROR-Gamma Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Nuclear Receptor ROR-Gamma Market
Table Key Manufacturers Nuclear Receptor ROR-Gamma Product Type
Table Mergers & Acquisitions Planning
Table 4SC AG Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of 4SC AG
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 4SC AG 2017-2022
Table 4SC AG Main Business
Table 4SC AG Recent Development
Table Celgene Corporation Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Celgene Corporation
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celgene Corporation 2017-2022
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Aurigene Discovery Technologies Limited Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Aurigene Discovery Technologies Limited
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aurigene Discovery Technologies Limited 2017-2022
Table Aurigene Discovery Technologies Limited Main Business
Table Aurigene Discovery Technologies Limited Recent Development
Table Advinus Therapeutics Ltd. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Advinus Therapeutics Ltd.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Advinus Therapeutics Ltd. 2017-2022
Table Advinus Therapeutics Ltd. Main Business
Table Advinus Therapeutics Ltd. Recent Development
Table Bristol-Myers Squibb Company Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Bristol-Myers Squibb Company
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb Company 2017-2022
Table Bristol-Myers Squibb Company Main Business
Table Bristol-Myers Squibb Company Recent Development
Table Arrien Pharmaceuticals, LLC Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Arrien Pharmaceuticals, LLC
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Arrien Pharmaceuticals, LLC 2017-2022
Table Arrien Pharmaceuticals, LLC Main Business
Table Arrien Pharmaceuticals, LLC Recent Development
Table Genfit SA Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Genfit SA
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Genfit SA 2017-2022
Table Genfit SA Main Business
Table Genfit SA Recent Development
Table Brickell Biotech, Inc. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Brickell Biotech, Inc.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Brickell Biotech, Inc. 2017-2022
Table Brickell Biotech, Inc. Main Business
Table Brickell Biotech, Inc. Recent Development
Table Biogen, Inc. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Biogen, Inc.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biogen, Inc. 2017-2022
Table Biogen, Inc. Main Business
Table Biogen, Inc. Recent Development
Table Genentech, Inc. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Genentech, Inc.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Genentech, Inc. 2017-2022
Table Genentech, Inc. Main Business
Table Genentech, Inc. Recent Development
Table Nuevolution AB Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Nuevolution AB
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Nuevolution AB 2017-2022
Table Nuevolution AB Main Business
Table Nuevolution AB Recent Development
Table Teijin Pharma Limited Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Teijin Pharma Limited
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teijin Pharma Limited 2017-2022
Table Teijin Pharma Limited Main Business
Table Teijin Pharma Limited Recent Development
Table GlaxoSmithKline Plc Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of GlaxoSmithKline Plc
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GlaxoSmithKline Plc 2017-2022
Table GlaxoSmithKline Plc Main Business
Table GlaxoSmithKline Plc Recent Development
Table Vitae Pharmaceuticals, Inc. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Vitae Pharmaceuticals, Inc.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Vitae Pharmaceuticals, Inc. 2017-2022
Table Vitae Pharmaceuticals, Inc. Main Business
Table Vitae Pharmaceuticals, Inc. Recent Development
Table Phenex Pharmaceuticals AG Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Phenex Pharmaceuticals AG
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Phenex Pharmaceuticals AG 2017-2022
Table Phenex Pharmaceuticals AG Main Business
Table Phenex Pharmaceuticals AG Recent Development
Table Lead Pharma Holding B.V. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Lead Pharma Holding B.V.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Lead Pharma Holding B.V. 2017-2022
Table Lead Pharma Holding B.V. Main Business
Table Lead Pharma Holding B.V. Recent Development
Table Hanmi Pharmaceuticals, Co. Ltd. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Hanmi Pharmaceuticals, Co. Ltd.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hanmi Pharmaceuticals, Co. Ltd. 2017-2022
Table Hanmi Pharmaceuticals, Co. Ltd. Main Business
Table Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table Visionary Pharmaceuticals, Inc. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Visionary Pharmaceuticals, Inc.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Visionary Pharmaceuticals, Inc. 2017-2022
Table Visionary Pharmaceuticals, Inc. Main Business
Table Visionary Pharmaceuticals, Inc. Recent Development
Table Reata Pharmaceuticals, Inc. Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Reata Pharmaceuticals, Inc.
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Reata Pharmaceuticals, Inc. 2017-2022
Table Reata Pharmaceuticals, Inc. Main Business
Table Reata Pharmaceuticals, Inc. Recent Development
Table Karo Bio AB Company Profile
Table Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification of Karo Bio AB
Table Nuclear Receptor ROR-Gamma Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Karo Bio AB 2017-2022
Table Karo Bio AB Main Business
Table Karo Bio AB Recent Development
Figure Global Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Global Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2017-2022)
Table Global Nuclear Receptor ROR-Gamma Sales by Regions (2017-2022)
Figure Global Nuclear Receptor ROR-Gamma Sales Market Share by Regions in 2021
Table Global Nuclear Receptor ROR-Gamma Revenue by Regions (2017-2022)
Figure Global Nuclear Receptor ROR-Gamma Revenue Market Share by Regions in 2021
Figure North America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Europe Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Asia-pacific Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure South America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure North America Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2017-2022)
Table North America Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
Table North America Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2017-2022)
Figure North America Nuclear Receptor ROR-Gamma Sales Market Share by Countries in 2021
Table North America Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
Table North America Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2017-2022)
Figure North America Nuclear Receptor ROR-Gamma Revenue Market Share by Countries in 2021
Figure United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Canada Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Mexico Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Table North America Nuclear Receptor ROR-Gamma Revenue by Manufacturer (2021)
Figure North America Nuclear Receptor ROR-Gamma Revenue Market Share by Manufacturer in 2021
Table North America Nuclear Receptor ROR-Gamma Sales by Type (2017-2022)
Table North America Nuclear Receptor ROR-Gamma Sales Share by Type (2017-2022)
Table North America Nuclear Receptor ROR-Gamma Sales by Application (2017-2022)
Table North America Nuclear Receptor ROR-Gamma Sales Share by Application (2017-2022)
Figure Europe Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2017-2022)
Table Europe Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
Table Europe Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2017-2022)
Figure Europe Nuclear Receptor ROR-Gamma Sales Market Share by Countries in 2021
Table Europe Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
Table Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2017-2022)
Figure Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Countries in 2021
Figure Germany Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure UK Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure France Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Russia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Italy Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Spain Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Table Europe Nuclear Receptor ROR-Gamma Revenue by Manufacturer (2021)
Figure Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Manufacturer in 2021
Table Europe Nuclear Receptor ROR-Gamma Sales by Type (2017-2022)
Table Europe Nuclear Receptor ROR-Gamma Sales Share by Type (2017-2022)
Table Europe Nuclear Receptor ROR-Gamma Sales by Application (2017-2022)
Table Europe Nuclear Receptor ROR-Gamma Sales Share by Application (2017-2022)
Figure Asia-pacific Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2017-2022)
Table Asia-pacific Nuclear Receptor ROR-Gamma Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Nuclear Receptor ROR-Gamma Sales Market Share by Countries in 2021
Table Asia-pacific Nuclear Receptor ROR-Gamma Revenue by Countries (2017-2022)
Table Asia-pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Countries in 2021
Figure China Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure South Korea Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Japan Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Australia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure India Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Figure Southeast Asia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2017-2022)
Table Asia-pacific Nuclear Receptor ROR-Gamma Revenue by Manufacturer (2021)
Figure Asia-pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Nu
4SC AG
Celgene Corporation
Aurigene Discovery Technologies Limited
Advinus Therapeutics Ltd.
Bristol-Myers Squibb Company
Arrien Pharmaceuticals, LLC
Genfit SA
Brickell Biotech, Inc.
Biogen, Inc.
Genentech, Inc.
Nuevolution AB
Teijin Pharma Limited
GlaxoSmithKline Plc
Vitae Pharmaceuticals, Inc.
Phenex Pharmaceuticals AG
Lead Pharma Holding B.V.
Hanmi Pharmaceuticals, Co. Ltd.
Visionary Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc.
Karo Bio AB